Determining the feasibility of linked claims and vaccination data for a COVID-19 vaccine pharmacoepidemiological study in Germany—RiCO feasibility study protocol by Peter Ihle, Brigitte Keller-Stanislawski, Ingo Meyer, Nina Timmesfeld, Robin Denz, Katherina Meiszl, Katrin Scholz, Doris Oberle, Ursula Drechsel-Bäuerle, Hans H Diebner

Get full text

Alpha-synuclein misfolding as fluid biomarker for Parkinson’s disease measured with the iRS platform by Martin Schuler, Grischa Gerwert, Marvin Mann, Nathalie Woitzik, Lennart Langenhoff, Diana Hubert, Deniz Duman, Adrian Höveler, Sandy Galkowski, Jonas Simon, Robin Denz, Sandrina Weber, Eun-Hae Kwon, Robin Wanka, Carsten Kötting, Jörn Güldenhaupt, Léon Beyer, Lars Tönges, Brit Mollenhauer, Klaus Gerwert

Get full text

Comparing the effectiveness of different vaccines in individuals with and without autoimmune diseases: a study protocol for a target trial emulation by Robin Denz, Heike van de Sand, Jale Basten, Katharina Meiszl, Marianne Tokic, Theresa Oganowski, Thomas Grüter, Thomas Grüter, Stephanie Stock, Dusan Simic, Arim Shukri, Uta Kiltz, Uta Kiltz, Maria Zacharopoulou, Horst Christian Vollmar, Ina Carola Otte, Chantal Giehl, Chantal Giehl, Romy Lauer, Romy Lauer, Anastasia Suslow, Andreas Stallmach, Anika Franz, Ursula Marschall, Joachim Saam, Catharina Schumacher, Katja Blaschke, Ingo Meyer, Kerstin Hellwig, Nina Timmesfeld, The VAC-MAC Consortium

Get full text